Common use of ARIAD AP23573 Development Program Reports Clause in Contracts

ARIAD AP23573 Development Program Reports. During the Term, in addition to the requirements set forth in Sections 3.3.4 and 3.3.6, ARIAD shall provide the Project Committee with [***] written reports that summarize ARIAD’s and its Pharmaceutical Partners’ efforts to obtain Regulatory Approval for AP23573 and to manufacture and supply API to ICON according to this Agreement and the Supply Agreement. ICON acknowledges that all reports provided by ARIAD pursuant to this Section 3.3.8 are ARIAD Confidential Information and shall use such information only for purposes expressly permitted under this Agreement.

ARIAD AP23573 Development Program Reports. During the Term, in addition to the requirements set forth in Sections 3.3.4 and 3.3.6, ARIAD shall provide the Project Committee with [***] written reports that summarize ARIAD’s and its Pharmaceutical Partners’ efforts to obtain Regulatory Approval regulatory approval for AP23573 in any territory, and its progress in arranging to manufacture and supply API to ICON MEDINOL with AP23573 on a timely basis according to this Agreement and the Supply AgreementAgreement (in other words, ARIAD’s progress with its manufacturing development program for AP23573). ICON MEDINOL acknowledges that all reports provided by ARIAD pursuant to this Section 3.3.8 3.4.5 are ARIAD Confidential Information and shall use such information only for purposes expressly permitted under this Agreement.

ARIAD AP23573 Development Program Reports. During the Term, in addition to the requirements set forth in Sections 3.3.4 and 3.3.6, ARIAD shall provide the Project Committee with [*******] written reports that summarize ARIAD’s and its Pharmaceutical Partners’ efforts to obtain Regulatory Approval regulatory approval for AP23573 in any territory, and its progress in arranging to manufacture and supply API to ICON MEDINOL with AP23573 on a timely basis according to this Agreement and the Supply AgreementAgreement (in other words, ARIAD’s progress with its manufacturing development program for AP23573). ICON MEDINOL acknowledges that all reports provided by ARIAD pursuant to this Section 3.3.8 3.4.5 are ARIAD Confidential Information and shall use such information only for purposes expressly permitted under this Agreement.